FDA Approved: TAVALISSE — Original Application (Rigel Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved TAVALISSE (fostamatinib) via an original application for adults with chronic immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Tavalisse (fostamatinib)

Snippet

ORIG AP for TAVALISSE (FOSTAMATINIB)